Home/Filings/4/0001544227-21-000013
4//SEC Filing

Owens Julia C. 4

Accession 0001544227-21-000013

CIK 0001544227other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:47 PM ET

Size

5.8 KB

Accession

0001544227-21-000013

Insider Transaction Report

Form 4
Period: 2021-03-17
Owens Julia C.
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2021-03-17+24,00024,000 total
    Exercise: $2.29Exp: 2031-03-16Common Stock (24,000 underlying)
Footnotes (1)
  • [F1]One-third (1/3) of the shares subject to this option shall vest on February 1, 2022, and one twenty-fourth (1/24th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. However, all such options, to the extent outstanding immediately prior to a Change in Control (as defined in the 2019 Equity Incentive Plan), will be (or will be deemed to have been) fully vested and exercisable as of immediately prior to such Change in Control.

Issuer

Millendo Therapeutics, Inc.

CIK 0001544227

Entity typeother

Related Parties

1
  • filerCIK 0001760219

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:47 PM ET
Size
5.8 KB